Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 01, 2016	Sep. 25, 2015
Current assets:
Cash and cash equivalents	$ 467,099	$ 531,926
Restricted cash	4,331	2,936
Short-term investments	139,144	138,901
Accounts receivable, net of allowance for doubtful accounts of $1,456 and $1,542	89,935	101,563
Inventories	14,237	13,872
Prepaid expenses and other current assets	23,195	32,031
Total current assets	737,941	821,229
Long-term investments	266,904	321,015
Property, plant and equipment, net	410,063	403,091
Intangible assets, net	224,151	127,507
Goodwill	308,374	307,708
Deferred taxes	154,277	143,279
Other non-current assets	11,894	9,464
Total assets	2,113,604	2,133,293
Current liabilities:
Accounts payable	12,207	20,710
Accrued liabilities	159,635	169,307
Income taxes payable	2,701	754
Deferred revenue	21,992	18,910
Total current liabilities	196,535	209,681
Long-term deferred revenue	33,813	30,581
Other non-current liabilities	71,074	77,024
Total liabilities	301,422	317,286
Stockholders' equity:
Additional paid-in capital	0	17,571
Retained earnings	1,816,318	1,800,857
Accumulated other comprehensive income/(loss)	(12,923)	(11,462)
Total stockholders’ equity – Dolby Laboratories, Inc.	1,803,496	1,807,068
Controlling interest	8,686	8,939
Total stockholders’ equity	1,812,182	1,816,007
Total liabilities and stockholders’ equity	2,113,604	2,133,293
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 52,089,249 shares issued and outstanding at January 1, 2016 and 50,291,426 at September 25, 2015
Stockholders' equity:
Common stock	52	51
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 48,681,489 shares issued and outstanding at January 1, 2016 and 50,743,311 at September 25, 2015
Stockholders' equity:
Common stock	$ 49	$ 51